Waters reports second quarter 2026 financial results
Total revenue reached $1.645 billion, exceeding guidance, while adjusted EPS was $3.05, and the company raised full-year guidance.
See the latest news and media coverage for Waters. We track all announcements, press releases, and industry mentions in real time, all in one place.
Analytical instruments, life science tools, and diagnostic solutions
waters.comLast updated
In short: Waters posted strong Q2 2026 results, raised guidance, and expanded HPV screening and mass spectrometry offerings
Total revenue reached $1.645 billion, exceeding guidance, while adjusted EPS was $3.05, and the company raised full-year guidance.
The Cyclic IMS P20 and Xevo MRT P10 set new benchmarks in structural/spatial omics and multiomics research.
The system reduces detection time by 3 hours and increases vial loading capacity by 50%.
The benchtop HRMS offers up to 20x higher MS/MS sensitivity and 2x faster speeds, enabling deeper biological insight.
Waters Corp stock is back in focus after an analyst overview on September 20, 2026 highlighted an Outperform rating with a USD 435 price target...
Everlywell Announces Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. to Patients CI...
Waters Corporation recently announced that Senior Vice President of the Waters Analytical Sciences...
Waters Corporation serves scientific laboratories with analytical instruments, software and consumables, while its S&P 500 ...
Track Waters and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Waters and other trending companies.